References
- Sandberg-Gertzen H, Järnerot G, Kraaz W. Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties. Gastroenterology 1986; 90: 1024–30
- Mohnsen A QM, Mulvey D, Priddle J D., Parsons D S., Jewell D P. Effects of olsalazine in the jejunum of the rat. Gut 1987; 28: 346–52
- Goerg K J., Wanitschke R, Gabbert H, Breiling J, Franke M, Meyer zum Büschenfelde K-H. Azodisalicylate (azodisal sodium) causes intestinal secretion. Digestion 1987; 37: 79–87
- Raimundo A H., Patil D H., Frost P G., Silk D BA. Effects of olsalazine and sulphasalazine on jejunal and ileal water and electrolyte absorption in normal human subjects. Gut 1991; 32: 270–4
- Evans D F., Pye G, Bramley R, Clark A G., Dyson T J., Hardcastle J D. Measurements of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988; 88: 1035–41
- Fallingborg J, Christensen L A., Ingeman-Nielsen M, Jacobsen B A., Abildgaard K, Rasmussen H H. pH profile and regional transit times of the gut measured by a radiotelemetry device. Aliment Pharmacol Ther 1989; 3: 605–13
- Watson W C., Paton E. Studies on intestinal pH by radiotele-metering. Gut 1965; 6: 606–12
- Scheurlen C, Wedel S, Kruis W, Zwiebel F M., Allgayer H, Scholz R. Olsalazine-related diarrhoea: does rat intestine adapt in vivo?. Scand J Gastroenterol 1992; 27: 311–6